MedPath

Comparison of standard method of pre-oxygenation with heated humidified high flow nasal canula (HHHFNC)for induction of anaesthesia and fiber optic nasal intubation in head and neck cancer surgery.

Recruiting
Conditions
Malignant neoplasms of lip, oral cavity and pharynx, (2) ICD-10 Condition: O||Medical and Surgical,
Registration Number
CTRI/2022/06/043234
Brief Summary

To prevent life-threatening eventsduring induction of general anaesthesia, pre-oxygenation protocol should extendthe apnea period safely. *Fisher&paykel AIRVO2 humidification high flow system* can deliverwarm and humidified oxygen through a specially designed nasal cannula cab bedelivered through high flow nasal cannula at a rate of 60l/min. Several studieshave shown that nasal delivery of humidified oxygen to paralyzed andanaesthetized patients maintains oxygenation and achieves acceptable carbon dioxideconcentrations.

We hypothesis that an extended apneic period withpre-oxygenation via the HFNC could be more beneficial to patients undergoinggeneral anaesthesia and fibre-optic nasal intubation compared with the standardtechnique

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
74
Inclusion Criteria
  • 1.Age18 -80 years.
  • 2.Patients undergoing head & neck surgery 3.ASA I, II.
Exclusion Criteria
  • 1.Patient refusal.
  • 2.Anticipated difficult airway 3.Mouth opening < 2 finger breadth 4.Patients who feel difficulty during HFNC will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare PaO2 at predefined time pointsTime points will be: | 1. Pre induction (room air) ABG | 2. 3 minute after pre-oxygenation | 3. 90 second after injection rocuronium | 4. just after successful intubation
Secondary Outcome Measures
NameTimeMethod
1.Comparison in change in PaCO2 & ABG at different predefined time points.2.Drop in Saturation during intubation

Trial Locations

Locations (1)

National cancer Institute

🇮🇳

Jhajjar, HARYANA, India

National cancer Institute
🇮🇳Jhajjar, HARYANA, India
Dr Brajesh Kumar Ratre
Principal investigator
8696156799
brajesh.ratre@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.